Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2005
06/02/2005WO2005050191A1 Method of simultaneously analyzing oxidatively injured guanine compound and substance correcting the concentration thereof and analzyer to be used in the analysis method
06/02/2005WO2005050171A2 Methods and compositions relating to single reactive center reagents
06/02/2005WO2005050164A2 Detection systems and methods
06/02/2005WO2005049868A1 Methods and agents for screening for compounds capable of modulating her2 expression
06/02/2005WO2005049867A1 Methods for identifying modulators of quadruplex nucleic acids
06/02/2005WO2005049866A2 Methods of detecting charcot-marie tooth disease type 2a
06/02/2005WO2005049865A2 Markers for stem cells and transplantation compatibility
06/02/2005WO2005049864A1 Method of diagnosing cancer
06/02/2005WO2005049863A2 Identification of diagnostic markers for communicable subacute spongiform encephalopathies
06/02/2005WO2005049861A2 Method for the analysis of gynaecological cell proliferative disorders
06/02/2005WO2005049860A2 Diagnostic and therapeutic methods and assays
06/02/2005WO2005049859A1 Nucleic acid detection
06/02/2005WO2005049858A1 Method of determining substrate contained in hemoglobin-containing sample
06/02/2005WO2005049857A1 Method of assyaing glycoprotein
06/02/2005WO2005049856A2 Methods and apparatus for the rapid detection of microorganisms collected from infected sites
06/02/2005WO2005049854A1 Biosensor having soil microorganism housed therein and use thereof
06/02/2005WO2005049853A2 Compositions and methods for screening pro-apoptotic compounds
06/02/2005WO2005049848A2 Nucleic acid hybridization methods
06/02/2005WO2005049838A2 Syk-targeted nucleic acid interference
06/02/2005WO2005049832A2 FcϜRIIA-SPECIFIC NUCLEIC ACID INTERFERENCE
06/02/2005WO2005049830A1 METHOD OF DESIGNING siRNA
06/02/2005WO2005049829A1 Process
06/02/2005WO2005049828A1 Nucleic acids specifically binding bioactive ghrelin
06/02/2005WO2005049826A1 Method of detecting target molecule by using aptamer
06/02/2005WO2005049825A1 Method of detecting signal transduction by g protein-coupled receptor using germination baculovirus
06/02/2005WO2005049821A1 METHOD OF EVALUATING RNAi ACTIVITY AND miRNA ACTIVITY
06/02/2005WO2005049817A2 Self-cleaving ribozymes and uses thereof
06/02/2005WO2005049809A1 Inhibition assay method and device for detection of antibiotics
06/02/2005WO2005049806A2 Novel nucleic acids and polypeptides
06/02/2005WO2005049800A2 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell
06/02/2005WO2005049799A2 Chimeric chemokine receptor polypeptides
06/02/2005WO2005049798A2 Chromosome 5 genetic variants related to dyslexia
06/02/2005WO2005049796A2 Chromosome 5 genetic variants related to dyslexia
06/02/2005WO2005049795A2 Mammalian cell lines for detecting, monitoring, and optimizing oligonucleotide-mediated chromosomal sequence alteration
06/02/2005WO2005049794A2 Methods of characterizing infectious bursal disease virus
06/02/2005WO2005049652A2 Methods of generating antibody diversity in vitro
06/02/2005WO2005049648A2 Chimeric or fusion constructs of insulin-like growth factor binding proteins as chemotherapeutic agents
06/02/2005WO2005049639A2 Compositions and methods for protein isolation
06/02/2005WO2005049636A2 Method of analyzing protein
06/02/2005WO2005049063A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
06/02/2005WO2005048936A2 Modulators of dimethylarginine dimethylaminohydrolase and methods of use thereof
06/02/2005WO2005048834A1 Long term analyte sensor array
06/02/2005WO2005048823A2 Modeling of systemic inflammatory response to infection
06/02/2005WO2005048818A2 Methods of diagnosing renal disease
06/02/2005WO2005038968A3 Suspension for the generation of a current of electrons and the use and the preparation thereof
06/02/2005WO2005033711A3 Clot lysis assay
06/02/2005WO2005033341A3 Use of cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof
06/02/2005WO2005033335A3 Microsensors and nanosensors for chemical and biological species with surface plasmons
06/02/2005WO2005033158A3 Attachment of molecules to surfaces
06/02/2005WO2005031349A3 Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor
06/02/2005WO2005031304A3 Quantification of analytes using internal standards
06/02/2005WO2005029039A3 Non-radioactive inositol phosphate assay for phospholipase c-coupled drug target screening
06/02/2005WO2005028675A3 Methods for detecting, diagnosing and treating hepatocellular carcinomas (hcc)
06/02/2005WO2005026393A3 Biological particulate matter analogue
06/02/2005WO2005026386A9 Insulin-like growth factor-1 receptor (igf-1r) polymorphic alleles and use of the same to identify dna markers for reproductive longevity
06/02/2005WO2005025497A3 Hpv cd8+ t-cell epitopes
06/02/2005WO2005024056A3 Method for the detection of cytosine methylations in dna with the aid of scorpion primers
06/02/2005WO2005014785A3 Conditionally-immortalized hematopoietic progenitor cell lines
06/02/2005WO2005013889A9 Truncated fragments of alpha-synuclein in lewy body disease
06/02/2005WO2005005613A3 Dsrna induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein
06/02/2005WO2005000192A3 Glycogen synthase kinase-3 inhibitors
06/02/2005WO2004112572A3 Monitoring immunologic, hematologic and inflammatory diseases
06/02/2005WO2004110384A3 Hiv-1 envelope glycoproteins having unusual disulfide structure
06/02/2005WO2004108081A3 Oligonucleotide synthesis with alternative solvents
06/02/2005WO2004096984A3 Preservation of rna in a biological sample
06/02/2005WO2004093784A3 Systems and methods for blood glucose sensing
06/02/2005WO2004092728A3 Methods of measuring the ability of a test compound to inactivate a biological target in cells of a subject
06/02/2005WO2004092417A3 Molecular correlates of cocaine addiction and methods for their use
06/02/2005WO2004092384A3 Means and methods for diagnosing and treating affective disorders
06/02/2005WO2004090506A3 Surfaces that selectively bind to moieties
06/02/2005WO2004085670A3 Polarization detection
06/02/2005WO2004083393A3 Enhanced protein thermostability and temperature resistance
06/02/2005WO2004081187A3 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
06/02/2005WO2004075812A3 Diagnostics and therapeutics for diseases associated with phosphodiesterase 3b (pde3b)
06/02/2005WO2004074320A3 Therapeutic targets in cancer
06/02/2005WO2004065545A3 Diagnosis and prognosis of breast cancer patients
06/02/2005WO2004058154A3 Method of identifying therapeutic agents
06/02/2005WO2004052918A3 Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides
06/02/2005WO2004048255A3 Dispersion of carbon nanotubes by nucleic acids
06/02/2005WO2004041212A3 Apkc isoforms in nervous system disorders and cancer
06/02/2005WO2004013347A8 Methods of identifying compounds that modulate protein activity
06/02/2005WO2004002295A3 Diagnosing predisposition to fat deposition and associated condition
06/02/2005WO2003068932A8 Method for crystallizing human gsk3 and novel crystal structure thereof
06/02/2005WO2003066667A3 Method and apparatus for performing submicroliter reactions with nucleic acids or proteins
06/02/2005US20050120418 Tomatoes having altered acid invertase activity due to non-transgenic alterations in acid invertase genes
06/02/2005US20050120413 Expression vector comprising polynucleotide encoding aberrant adp-glucose pyrophosphorylase for use as tool in generating plants with increase yields in high heat environments
06/02/2005US20050120396 Human MEKK1 protein and nucleic acid molecules and uses therefor
06/02/2005US20050120393 Nucleotide sequences associated with prostate specific gene expression for use as tool in diagnosis, prognosis, classification, prevention and treatment of cell proliferative disorders of urogenital systems
06/02/2005US20050119835 Method and apparatus for analysis of molecular combination based on computational estimation of electrostatic affinity using basis expansions
06/02/2005US20050119834 Method and apparatus for analysis of molecular combination based on computations of shape complementarity using basis expansions
06/02/2005US20050119536 Diagnostics and therapeutics for arterial wall disruptive disorders
06/02/2005US20050119477 Method for determining specific groups constituting heparins or low molecular weight heparins
06/02/2005US20050119471 RNA viral sequences for use in development of vaccine to prevent gastrointestinal disorders in infants and young children
06/02/2005US20050119459 Expression vector comprising nucleotide sequences coding late-gestation lung 1 (LGL-1) for use as tool in diagnosis prevention and treatment of respiratory system disorders
06/02/2005US20050119458 Transport protein for use in identifying modulator for prevention and treatment of cell proliferative, skin and psychological disorders; anticonvulsants; insecticides; pesticides; anthelmintics
06/02/2005US20050119457 Human proteins
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119214 Nuclease resistant double-stranded ribonucleic acid
06/02/2005US20050119213 Vascular therapeutics
06/02/2005US20050119210 Using genes encoding transmembrane protein as markers; targets for cancer therapy; drug screening
1 ... 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 ... 3003